Trials / Completed
CompletedNCT06974292
The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers
The Mass Balance and Biotransformation Study of [14C]VC005 in Chinese Healthy Adult Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]VC005 orally in Chinese healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]VC005 | Take a suspension of 50 mg VC005 ,containing about 120 μCi \[14C\]VC005, in fasting within 5 minutes |
Timeline
- Start date
- 2025-05-26
- Primary completion
- 2025-06-03
- Completion
- 2025-06-03
- First posted
- 2025-05-15
- Last updated
- 2025-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06974292. Inclusion in this directory is not an endorsement.